|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.388 SEK | -0.43% |
|
-0.43% | -29.54% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.43% | -0.43% | +15.67% | -11.37% | -29.54% | -61.76% | -82.52% | -97.17% | - | 21.41M | |
| -2.48% | -6.76% | +2.01% | +24.88% | +7.20% | +44.12% | +156.31% | +387.42% | +1,329.47% | 1,054B | |
| -1.94% | -5.41% | +7.26% | +5.28% | +22.15% | +61.19% | +58.12% | +48.33% | +105.21% | 621B | |
| -1.22% | -4.00% | +10.32% | +16.27% | +6.99% | +27.64% | +79.74% | +108.30% | +284.25% | 438B | |
| -1.12% | -3.68% | +0.28% | +2.80% | -0.37% | +26.89% | +20.58% | -8.02% | +28.69% | 325B | |
| -1.73% | -3.45% | +1.83% | +1.78% | +11.70% | +26.95% | +44.09% | +44.23% | +52.17% | 281B | |
| -1.95% | -13.92% | -6.33% | -17.12% | -10.34% | +15.96% | +19.76% | +42.62% | +176.63% | 262B | |
| -1.45% | -2.37% | +11.94% | +29.88% | -1.71% | -27.87% | -39.87% | +16.98% | +72.53% | 219B | |
| -1.45% | -3.51% | +1.33% | +1.21% | +8.52% | +19.58% | +56.18% | +45.15% | +118.26% | 195B | |
| -0.91% | -4.56% | +4.70% | -7.34% | +6.03% | +16.10% | +68.60% | +91.58% | +52.14% | 163B | |
| -1.08% | +0.69% | -6.79% | -10.60% | -2.67% | -4.40% | -33.27% | -39.34% | -34.36% | 140B | |
| -0.80% | -8.83% | +5.70% | +7.17% | +5.02% | +0.80% | +34.98% | +140.60% | +440.14% | 122B | |
| -2.03% | +0.33% | +3.41% | +0.14% | +7.82% | +22.86% | -6.10% | -14.32% | -24.24% | 121B | |
| -1.69% | -4.12% | -1.92% | -12.31% | +5.26% | +34.82% | +45.47% | +6.86% | -5.66% | 104B | |
| -2.08% | -0.37% | -0.05% | -6.81% | -8.73% | -9.62% | -19.42% | -14.85% | -0.17% | 106B | |
| +0.15% | -3.98% | -2.81% | -15.66% | -12.16% | +5.91% | +88.13% | +70.14% | +471.66% | 73.3B | |
| -1.60% | -3.35% | +35.28% | +20.96% | +32.72% | +78.55% | -2.37% | -3.69% | -47.43% | 55.91B | |
| -1.67% | -3.43% | +13.05% | -0.69% | -7.97% | -3.66% | +14.18% | -11.49% | +242.95% | 54.26B | |
| +0.17% | -3.44% | +4.82% | -5.48% | +10.18% | +21.68% | +23.14% | +43.01% | +21.70% | 51.76B | |
| -1.29% | -1.40% | +7.52% | +0.87% | -3.87% | -1.88% | +14.65% | - | - | 43.02B | |
| Average | -1.35% | -0.76% | +5.36% | +1.19% | +2.31% | +14.69% | +27.02% | +45.07% | +182.44% | 221.34B | |
| Weighted average by Cap. | -1.74% | -1.44% | +3.78% | +8.20% | +6.50% | +28.90% | +64.12% | +125.41% | +410.64% |
- Stock Market
- Stocks
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
